Well, we’ve made it to the final day of this year’s virtual J.P. Morgan Healthcare Conference. I’m nowhere near as exhausted as I usually am by the long days, but I am starting to miss actually bumping into people in San Francisco. What’s been your takeaway from the virtual conference? Let me know at [email protected].
And as we head toward the end of a busy week, I wanted to introduce you all to the newest member of the team, Allison DeAngelis! Say hi via email at [email protected] and follow her on Twitter at @ADeAngelis_bio.
Ro, the direct-to-consumer digital health startup, announced Wednesday that it will teaming up with computer-vision startup Gauss to offer at-home rapid COVID-19 antigen tests.
The partnership will start once Gauss's test gets an emergency use authorization from the FDA.
A top healthcare VC predicted microbiome drugs would rebound in 2021 as part of Business Insider's year-end roundup of healthcare predictions.
Though the biotech industry's infatuation with the promise of the bacteria in our gut dates back years, research failures and the 2019 uBiome scandal previously chilled investors' interests.
